The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.

The widespread use of primaquine (PQ) radical cure for P. vivax, is constrained by concerns over its safety. We used routinely collected patient data to compare the overall morbidity and mortality in patients treated with and without PQ without prior testing of Glucose-6-Phosphate-Dehydrogenase (G6P...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Kamala Thriemer, Jeanne-Rini Poespoprodjo, Enny Kenangalem, Nicholas M Douglas, Paulus Sugiarto, Nicholas M Anstey, Julie Anne Simpson, Ric N Price
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Public Library of Science (PLoS) 2020-11-01
Saila:PLoS Neglected Tropical Diseases
Sarrera elektronikoa:https://doi.org/10.1371/journal.pntd.0008838